APA (7th ed.) Citation

ZX, Z., JY, W., SW, Z., & ML, Y. (2024). Reply to: "Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed". Hepatology international, 18(5), 1589. https://doi.org/10.1007/s12072-024-10682-6

Chicago Style (17th ed.) Citation

ZX, Zeng, Wu JY, Zhuang SW, and Yan ML. "Reply to: "Is the TAE Score a Promising Prognostic Predictor for Unresectable Hepatocellular Carcinoma Treated with TACE Plus Lenvatinib with PD‑1 Inhibitors? Further Validation Should Be Performed"." Hepatology International 18, no. 5 (2024): 1589. https://doi.org/10.1007/s12072-024-10682-6.

MLA (9th ed.) Citation

ZX, Zeng, et al. "Reply to: "Is the TAE Score a Promising Prognostic Predictor for Unresectable Hepatocellular Carcinoma Treated with TACE Plus Lenvatinib with PD‑1 Inhibitors? Further Validation Should Be Performed"." Hepatology International, vol. 18, no. 5, 2024, p. 1589, https://doi.org/10.1007/s12072-024-10682-6.